Moderate up-regulation of HER2 in ER+/HER2− breast cancer cell lines was also observed by others in MCF7 cells subjected to long-term estrogen deprivation and tamoxifen treatment suggesting that this increased expression of HER2 might be responsible for attenuated responses to estrogen withdrawal and tamoxifen [47]. This evidence concerns the gene ERBB2 and breast carcinoma.